Powder: -20°C for 3 years | In solvent: -80°C for 1 year
VV116 (JT001) is a selective and orally active nucleoside antiviral agent against respiratory syncytial virus (RSV) and SARS-CoV-2 infection.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 21,500 | |||
5 mg | 在庫あり | ¥ 52,500 | |||
10 mg | 在庫あり | ¥ 83,500 | |||
25 mg | 在庫あり | ¥ 158,500 | |||
50 mg | 在庫あり | ¥ 224,500 | |||
100 mg | 在庫あり | ¥ 296,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 68,000 |
説明 | VV116 (JT001) is a selective and orally active nucleoside antiviral agent against respiratory syncytial virus (RSV) and SARS-CoV-2 infection. |
別名 | GS-621763-d1, JT001 |
分子量 | 502.54 |
分子式 | C24H30DN5O7 |
CAS No. | 2647442-33-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 245 mg/mL (419.92 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
VV116 2647442-33-7 Microbiology/Virology RSV SARS-CoV VV-116 VV 116 GS-621763-d1 JT-001 JT 001 JT001 Inhibitor inhibitor inhibit